KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Medpace Holdings (MEDP) Revenue (2016 - 2026)

Medpace Holdings filings provide 12 years of Revenue readings, the most recent being $706.6 million for Q1 2026.

  • On a quarterly basis, Revenue rose 26.5% to $706.6 million in Q1 2026 year-over-year; TTM through Mar 2026 was $2.7 billion, a 24.19% increase, with the full-year FY2025 number at $2.5 billion, up 19.97% from a year prior.
  • Revenue hit $706.6 million in Q1 2026 for Medpace Holdings, roughly flat from $708.4 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $708.4 million in Q4 2025 to a low of $330.9 million in Q1 2022.
  • Median Revenue over the past 5 years was $511.0 million (2024), compared with a mean of $511.3 million.
  • Biggest five-year swings in Revenue: rose 7.66% in 2024 and later skyrocketed 32.03% in 2025.
  • Medpace Holdings' Revenue stood at $394.1 million in 2022, then grew by 26.47% to $498.4 million in 2023, then rose by 7.66% to $536.6 million in 2024, then skyrocketed by 32.03% to $708.4 million in 2025, then decreased by 0.26% to $706.6 million in 2026.
  • The last three reported values for Revenue were $706.6 million (Q1 2026), $708.4 million (Q4 2025), and $659.9 million (Q3 2025) per Business Quant data.